Alfredo Molteni

MD
UOC Ematologia e CTMO, ASST Cremona, Cremona, Italy
Cremona, Lombardia, Italy

Presentation(s):

• OC 26.2 - Bortezomib for rituximab-refractory immune-mediated thrombotic thrombocytopenic purpura in the caplacizumab era: update of an Italian multicenter study

  Sunday, June 23, 2024
  15:00 – 15:15 ICT